Staff employed at University of Copenhagen – University of Copenhagen

Forward this page to a friend Resize Print Bookmark and Share

CTR > People and Networks > Staff

Procedural Aspects of Compulsory Licensing Under TRIPS: Report No. II of Webinar Series on Reinterpreting TRIPS in the Life Sciences

Publication: CommunicationReport

In 2013, Indian authorities granted a compulsory license to NATCO Pharmaceuticals for a patented pharmaceutical product sold by Bayer. This decision raised several complex issues regarding the grant a CL and their consistency with the principles and objectives of TRIPS. Furthermore, in January 2017 an amendment to the TRIPS agreement entered into force, allowing compulsory licensors to export their generic pharmaceuticals to least developed countries (LDC), further recalibrating the intersection between the patent institution and public interest. On this background, the webinar presentations and discussion addressed the framework and context for CL provided by the TRIPS convention. Both the specific requirements enshrined in TRIPS art 31 and the broader objectives and principles enshrined in TRIPS, e.g. transfer and dissemination of technology (art 7), protection of public health (art 8) and technology neutrality (art 27) where included in the discussion.
Original languageEnglish
Number of pages9
StatePublished - 28 Sep 2017

    Research areas

  • The Faculty of Law - TRIPS, Life Science, Patents, Compulsory Licensing, Access to Medicine, NATCO

ID: 184034088